Kensuke Moriwaki

664 total citations
44 papers, 454 citations indexed

About

Kensuke Moriwaki is a scholar working on Economics and Econometrics, Surgery and Oncology. According to data from OpenAlex, Kensuke Moriwaki has authored 44 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 11 papers in Surgery and 7 papers in Oncology. Recurrent topics in Kensuke Moriwaki's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Bone health and osteoporosis research (6 papers) and Hip and Femur Fractures (5 papers). Kensuke Moriwaki is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Bone health and osteoporosis research (6 papers) and Hip and Femur Fractures (5 papers). Kensuke Moriwaki collaborates with scholars based in Japan, United States and Netherlands. Kensuke Moriwaki's co-authors include Shinichi Noto, Shunya Ikeda, Tomoyuki Takura, Takeru Shiroiwa, Takashi Fukuda, Hirotaka Komaba, Masafumi Fukagawa, Isao Kamae, Haruhisa Fukuda and Kojiro Shimozuma and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Kensuke Moriwaki

39 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensuke Moriwaki Japan 10 135 92 85 84 72 44 454
Bernie McGowan Ireland 12 161 1.2× 91 1.0× 122 1.4× 39 0.5× 36 0.5× 33 400
Eduard Hermosilla Spain 7 175 1.3× 35 0.4× 216 2.5× 20 0.2× 91 1.3× 8 742
Na Tian China 13 84 0.6× 49 0.5× 17 0.2× 297 3.5× 40 0.6× 40 644
Mark Rutkowski United States 14 57 0.4× 33 0.4× 14 0.2× 303 3.6× 29 0.4× 18 561
S. Guillo France 9 163 1.2× 58 0.6× 23 0.3× 8 0.1× 53 0.7× 29 470
Anuja Mittalhenkle United States 12 157 1.2× 10 0.1× 162 1.9× 306 3.6× 65 0.9× 15 561
Steven E. Marx United States 16 65 0.5× 54 0.6× 13 0.2× 302 3.6× 17 0.2× 42 701
Zhi Tan Canada 13 101 0.7× 33 0.4× 30 0.4× 476 5.7× 23 0.3× 21 613
Mustafa Sevinç Türkiye 13 108 0.8× 17 0.2× 10 0.1× 231 2.8× 63 0.9× 49 476
Ronald K. Loo United States 14 305 2.3× 27 0.3× 17 0.2× 18 0.2× 79 1.1× 45 634

Countries citing papers authored by Kensuke Moriwaki

Since Specialization
Citations

This map shows the geographic impact of Kensuke Moriwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Moriwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Moriwaki more than expected).

Fields of papers citing papers by Kensuke Moriwaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Moriwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Moriwaki. The network helps show where Kensuke Moriwaki may publish in the future.

Co-authorship network of co-authors of Kensuke Moriwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Moriwaki. A scholar is included among the top collaborators of Kensuke Moriwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Moriwaki. Kensuke Moriwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moriwaki, Kensuke, et al.. (2024). EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan. Value in Health. 27(6). S111–S111.
2.
Yamaguchi, Motoko, Kensuke Moriwaki, & Kojiro Shimozuma. (2024). HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan. Value in Health. 27(6). S252–S252.
3.
Amaki, Makoto, Kensuke Moriwaki, Michikazu Nakai, et al.. (2023). Cost-effective analysis of transcatheter aortic valve replacement in patients with severe symptomatic aortic stenosis: A prospective multicenter study. Journal of Cardiology. 83(3). 169–176. 1 indexed citations
4.
Mo, Xiuting, et al.. (2022). Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan. Clinical Drug Investigation. 42(7). 599–609. 4 indexed citations
5.
Hoshino, Eri, Kensuke Moriwaki, Kotomi Sakai, et al.. (2022). Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan. The Journal of Pediatrics. 253. 101–106.e2. 5 indexed citations
6.
Moriwaki, Kensuke, Hiroshi Hayashi, Takashi Miyakoshi, et al.. (2022). EE361 Preliminary Cost-Effectiveness Analysis of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan. Value in Health. 25(7). S406–S406.
7.
Moriwaki, Kensuke, et al.. (2021). Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan. PharmacoEconomics - Open. 5(3). 437–447. 6 indexed citations
8.
Ohde, Sachiko, Kensuke Moriwaki, & Osamu Takahashi. (2021). Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification. BMC Endocrine Disorders. 21(1). 105–105. 4 indexed citations
9.
Moriwaki, Kensuke, et al.. (2021). Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in Japan. Value in Health Regional Issues. 28. 54–60. 4 indexed citations
10.
Moriwaki, Kensuke, et al.. (2020). Factors influencing the prescribed dose of opioid analgesics in cancer patients. Journal of Opioid Management. 16(4). 247–252. 1 indexed citations
11.
Noto, Shinichi, Osamu Takahashi, Takeshi Kimura, Kensuke Moriwaki, & Katsunori Masuda. (2020). The relationship between preference-based health-related quality of life and lifestyle behavior: a cross-sectional study on a community sample of adults who had undergone a health check-up. Health and Quality of Life Outcomes. 18(1). 267–267. 3 indexed citations
12.
Moriwaki, Kensuke & Haruhisa Fukuda. (2019). Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan. Osteoporosis International. 30(2). 299–310. 9 indexed citations
13.
Shiroiwa, Takeru, Takashi Fukuda, Shunya Ikeda, Tomoyuki Takura, & Kensuke Moriwaki. (2016). Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan. Value in Health. 20(3). 372–378. 117 indexed citations
14.
Moriwaki, Kensuke, et al.. (2016). A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women. Osteoporosis International. 28(2). 643–652. 9 indexed citations
15.
Fukuda, Haruhisa & Kensuke Moriwaki. (2016). Cost-Effectiveness Analysis of Safety-Engineered Devices. Infection Control and Hospital Epidemiology. 37(9). 1012–1021. 4 indexed citations
16.
Moriwaki, Kensuke & Shinichi Noto. (2015). Validation of Fracture Risk Model In Japanese Women Compared With Frax. Value in Health. 18(7). A698–A698. 1 indexed citations
17.
Fukuda, Takashi, Takeru Shiroiwa, Shunya Ikeda, et al.. (2013). Guideline for economic evaluation of healthcare technologies in Japan. 62(6). 325–640. 46 indexed citations
18.
Noto, Shinichi, et al.. (2011). PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPAN. Value in Health. 14(3). A45–A45. 2 indexed citations
19.
Goto, Shunsuke, Hirotaka Komaba, Kensuke Moriwaki, et al.. (2011). Clinical Efficacy and Cost-Effectiveness of Lanthanum Carbonate as Second-Line Therapy in Hemodialysis Patients in Japan. Clinical Journal of the American Society of Nephrology. 6(6). 1375–1384. 24 indexed citations
20.
国立極地研究所, Jiro Segawa, Yasushi Fukuda, et al.. (1991). Antarctic geoscience transect QML-1A and QML-1B. Institutional Repository National Institute of Polar Research (National Institute of Polar Research (Japan)). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernie McGowan Breakdown of academic impact, for papers by Eduard Hermosilla Breakdown of academic impact, for papers by Na Tian Breakdown of academic impact, for papers by Mark Rutkowski Breakdown of academic impact, for papers by S. Guillo Breakdown of academic impact, for papers by Anuja Mittalhenkle Breakdown of academic impact, for papers by Steven E. Marx Breakdown of academic impact, for papers by Zhi Tan Breakdown of academic impact, for papers by Mustafa Sevinç Breakdown of academic impact, for papers by Ronald K. Loo
Rankless by CCL
2026